EU OKs Roche`s Avastin for ovarian cancer
Zurich: The European Commission has approved Roche`s drug Avastin for treating women with newly diagnosed, advanced ovarian cancer, offering new options to sufferers previously limited to surgery and chemotherapy.
The Swiss drugmaker is the world`s largest maker of cancer drugs. The EU`s approval was granted for Avastin in combination with standard chemotherapy, it said in a statement on Friday.
"Today`s approval of Avastin marks the first major treatment advance in newly diagnosed ovarian cancer in 15 years," said Chief Medical Officer Hal Barron. "This is the fifth tumor type for which Avastin has been approved in Europe, making it one of few biologic drugs indicated for multiple cancers."
In two late-stage studies, Roche found that women with newly diagnosed advanced ovarian cancer who used Avastin and chemotherapy and then continued on just Avastin lived quite a bit longer without their disease getting worse compared with those who received only chemotherapy.
Ovarian cancer is the most deadly of the gynecological cancers, with 140,000 women dying from the disease each year globally, Roche said.
More from India
More from World
More from Sports
More from Entertaiment
- President Mukherjee inspect International Fleet Review at Vishakhapatnam
- Divyansh's death not an accident, but a murder?
- Dr Subhash Chandra Show: How realising the purpose of life gives you direction
- Was Divyansh sexually assaulted and then murdered?
- India takes inspiration from Iran; sets up 'Hanger of Kindness' in Delhi
- Oh so cute! PM Narendra Modi pulls Akshay Kumar's son Aarav Kumar's ear!-- See pic
- Ryan child death: Sexual assault allegations should be probed, says Manish Sisodia
- Not Delhi, but Varanasi and Muzaffarpur the most polluted cities in India
- 'Bajirao Mastani' still galloping at box office, mints Rs 350 cr!
- India brought Afghanistan athletes in chartered flight: Pakistan envoy impressed with SAG 2016